These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10668603)

  • 21. MDMA ("ecstasy") and neurotoxicity.
    Mithoefer M; Jerome L; Doblin R
    Science; 2003 Jun; 300(5625):1504-5; author reply 1504-5. PubMed ID: 12791964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 23. MDMA and serotonin: based on two cases.
    Garcia Cabeza I; Zabala A; Soto-Montenegro ML; Arango C
    Actas Esp Psiquiatr; 2005; 33(5):339-42. PubMed ID: 16155817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurotoxicity of the drug Ecstasy. Functional consequences of serotonergic hypoactivity].
    de Visme PG
    Ugeskr Laeger; 1998 Oct; 160(42):6088-91. PubMed ID: 9800515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    Silins E; Copeland J; Dillon P
    Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute and long-term effects of ecstasy].
    Salzmann J; Marie-Claire C; Noble F
    Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
    Schifano F; Di Furia L; Forza G; Minicuci N; Bricolo R
    Drug Alcohol Depend; 1998 Sep; 52(1):85-90. PubMed ID: 9788011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of MDMA (ecstasy) use and neurotoxicity.
    Franken IH
    Eur Psychiatry; 2001 Dec; 16(8):508-9. PubMed ID: 11777745
    [No Abstract]   [Full Text] [Related]  

  • 31. [Persisting and late onset psychotic disorder due to consumption of ecstasy (MDMA)].
    Boné Pina I; Ramos Gorostiza P; Villalba Yllán P; Valle Fernández J
    Actas Esp Psiquiatr; 2000; 28(1):61-5. PubMed ID: 10758429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ecstasy (MDMA) and oral health.
    Brand HS; Dun SN; Nieuw Amerongen AV
    Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term psychiatric and cognitive effects of MDMA use.
    McGuire P
    Toxicol Lett; 2000 Mar; 112-113():153-6. PubMed ID: 10720725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
    Falck RS; Wang J; Carlson RG; Siegal HA
    Addict Behav; 2006 Jan; 31(1):90-101. PubMed ID: 15922511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
    Gesi M; Ferrucci M; Giusiani M; Lenzi P; Lazzeri G; Alessandrì MG; Salvadorini A; Fulceri F; Pellegrini A; Fornai F; Paparelli A
    Microsc Res Tech; 2004 Jul; 64(4):297-303. PubMed ID: 15481049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric alterations in MDMA users: preliminary findings.
    Herning RI; Better W; Tate K; Cadet JL
    Ann N Y Acad Sci; 2005 Aug; 1053():20-7. PubMed ID: 16179502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
    Verheyden SL; Henry JA; Curran HV
    Hum Psychopharmacol; 2003 Oct; 18(7):507-17. PubMed ID: 14533132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.